M.B.A., MIT Sloan School of Management; B.A., economics, Mount Holyoke College
Summary of Experience
Ms. Pike applies her expertise in health economics, statistics, and large administrative claims and transaction-level databases to help resolve complex litigation questions and strategic business questions in a variety of contexts, including matters involving the False Claims Act, Antikickback Statute, and Controlled Substance Act. She has assisted several companies in developing Suspicious Order Monitoring programs, in building internal analytical programs to assess the risk of theft or diversion, and in responding to U.S. Drug Enforcement Administration (DEA) investigations related to controlled substance distribution. She also has extensive experience in developing flexible damages models for real-time use in high-stakes negotiations, and performing economic analyses and presenting findings to U.S. Attorney's Office investigators in numerous cases involving allegations of off-label promotion, kickback, or pricing issues.
Ms. Pike has managed a range of health care cases involving analysis of future lost profits; economic analysis of physician payment structures under capitation; studies of the cost effectiveness, budget impacts, and direct and indirect costs of illness associated with a variety of diseases; and pricing analyses for large multinational corporations across numerous industries. Ms. Pike has also applied economic theory and empirical estimation methods in a variety of product liability, breach of contract, intellectual property, and transfer-pricing engagements. She has published numerous articles in health care economics and clinical journals.